ResearcherChina Pharmaceutical UniversityNo recent work listed
Ping Li
Matched on ORCID iD 0000-0003-4150-3758; OpenAlex author ID A5100435589. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 4
- Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Co-author DOI 10.1007/s11427-019-1753-3↗
- Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis. Co-author DOI 10.1016/j.ejphar.2019.01.060↗
- Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol. Last author DOI 10.1208/s12248-013-9558-3↗
- Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Last author DOI 10.1042/bj20110297↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaojun Xu · 3 shared papers, 2014–2021 · strength 0.28
- Paper Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. DOI 10.1007/s11427-019-1753-3↗
- Paper Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrient… DOI 10.1016/j.ejphar.2019.01.060↗
- Paper Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by… DOI 10.1208/s12248-013-9558-3↗
- Pyone Myat Thu · 2 shared papers, 2019–2021 · strength 0.23
- Ji Li · 2 shared papers, 2019–2021 · strength 0.23
- Xiaoxiao Liu · 1 shared paper, 2021 · strength 0.14
- Peng Yang · 1 shared paper, 2021 · strength 0.14
- Zu‐Guo Zheng · 1 shared paper, 2019 · strength 0.09
- Ling Zhou · 1 shared paper, 2014 · strength 0.05
- Kan Ding · 1 shared paper, 2011 · strength 0.03
- Chenghao Shao · 1 shared paper, 2011 · strength 0.03
- Kai Song · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.